Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Integrating Modern Tech with Drupal
Organizations across industries are under immense pressure to scale their digital ecosystems efficiently while maintaining consistency and delivering seamless customer experiences. For enterprises…
|
Your Guide to Build Scalable Drupal Websites
Scalability is not just a buzzword—it's a necessity for organizations managing complex digital ecosystems. Whether you're a financial institution overseeing multiple regional websites or a…
|
Your Path to Drupal 9 and Beyond
Your Path to Drupal 9 and Beyond: What's in the Hood?The digital landscape is undergoing a seismic shift, and organizations face increasing pressure to adapt. For enterprises reliant on Drupal,…
|
Essential Features of Drupal 9 for Developers
Introduction to Drupal 9 and its End of LifeDrupal 9 is an open-source content management system (CMS) widely used for building websites and web applications. It's known for its flexibility,…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
